QlearQuil Leverages Brand Into Allergy Space, Absorbs Existing ‘Quil’ Sinus Products
This article was originally published in The Tan Sheet
Executive Summary
P&G enters the OTC allergy category with QlearQuil products “for the occasional allergy sufferer.” But the firm also could be on the spot to prevent consumer confusion about indications for products in the broad selection with “Quil” in their brands.
You may also be interested in...
FDA’s Proposed Name Review Pilot Offers Little Reason To Participate
A proposed FDA pilot program that would shift the burden for safety review of proprietary drug names from the agency to industry needs to account for key differences between OTC and Rx products and lacks participation incentives, pharmaceutical researchers say
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.